Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled, Double Blind, Randomized Trial of Acamprosate for the Treatment of Methamphetamine Dependence

NCT00571922 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00571922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00571922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled, Double Blind, Randomized Trial of Acamprosate for the Treatment of Methamphetamine Dependence
Lead sponsor
NYU Langone Health
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2007
Completion date
November 30, 2008
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine dependence, treatment seeking